0000950170-24-040320.txt : 20240402
0000950170-24-040320.hdr.sgml : 20240402
20240402170157
ACCESSION NUMBER: 0000950170-24-040320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240331
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stephens Kristin
CENTRAL INDEX KEY: 0001865490
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 24815365
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 35 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
4
1
ownership.xml
4
X0508
4
2024-03-31
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001865490
Stephens Kristin
C/O SYROS PHARMACEUTICALS, INC.
35 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
false
true
false
false
Chief Development Officer
false
Common Stock
2024-03-31
4
M
false
2000
A
17789
D
Common Stock
2024-03-31
4
M
false
11666
A
29455
D
Common Stock
2024-04-01
4
F
false
4218
5.12
D
25237
D
Restricted Stock Units
2024-03-31
4
M
false
2000
0.00
D
Common Stock
2000
4000
D
Restricted Stock Units
2024-03-31
4
M
false
11666
0.00
D
Common Stock
11666
23334
D
Represents shares of common stock received upon vesting of a restricted stock unit award.
Represents shares used to cover tax withholding upon the release of restricted stock units.
Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Represents a restricted stock unit award granted on February 15, 2022. These restricted stock units vest in four equal annual installments commencing on March 31, 2023.
Represents a restricted stock unit award granted on February 16, 2023. These restricted stock units vest in three equal annual installments commencing on March 31, 2024.
/s/ Todd Rosenthal, as attorney-in-fact
2024-04-02